Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morgan Stanley (NY: MS )

95.86 +1.07 (+1.13%)
Streaming Delayed Price Updated: 11:21 AM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Morgan Stanley

< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Morgan Stanley Just Raised Its Price Target on Micron (MU) Stock
Micron stock is rising higher on Thursday as investors learn of an increased price target for MU shares from Morgan Stanley analysts. 
Via InvestorPlace
US Stocks At Risk Due To Rising De-Dollarization Trend, Warns Morgan Stanley Wealth CIO
Shalett has raised concerns about the U.S. dollar's supremacy being at risk, which could negatively impact U.S. equities. 
Via Benzinga
Why Nordstrom Stock Popped Today
Nordstrom's founding family is exploring options to take the company private. 
Via The Motley Fool
The World’s Top 50 Largest Banks By Consolidated Assets
According to S&P, the four largest Chinese banks grew their assets by 4.1% in 2022, reaching a combined total of $19.8 trillion. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Micron Technology Stock Has 17% Downside, According to 1 Wall Street Analyst
AI is a catalyst for Micron, but Morgan Stanley analysts don't see value in the stock at these highs. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Analyst Scoreboard: 12 Ratings For Morgan Stanley
Via Benzinga
Behind the Scenes of Morgan Stanley's Latest Options Trends
Via Benzinga
Here's How Much You Would Have Made Owning Morgan Stanley Stock In The Last 5 Years
Via Benzinga
Morgan Stanley Unusual Options Activity
Via Benzinga
Aerospace Top Pick Jumps On Earnings As 'Harvest Period' Begins
Brazilian plane manufacturer Embraer rallies on Q4 results. Morgan Stanley named ERJ stock its top aerospace pick. 
Via Investor's Business Daily
New Clues Strongly Suggest This Is the "Confidential Stock" Warren Buffett Has Been Buying
Berkshire Hathaway is secretly building up its stake in one or more companies. New clues and details point to one very specific stock. 
Via The Motley Fool
Reddit Is Going Public Soon. Here's Why That Could Be Good News for Investment Banks.
Reddit's IPO could set the foundation for others going public in 2024. Here are the bank stocks that could get a big boost. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
3 AI Stocks to Sell in March Before They Crash & Burn
Discover three key AI stocks to sell before they plummet and the rally reverses, even though they have experienced recent gains. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Morgan Stanley Analyst Increasingly Bullish On Elon Musk's Tesla Optimus Venture As Jeff Bezos, Nvidia, Microsoft Pour $675M In FigureAI
Morgan Stanley analyst and Tesla Inc bull Adam Jonas sees the theme of humanoid robotics accelerating in the months. 
Via Benzinga
A Closer Look at Morgan Stanley's Options Market Dynamics
Via Benzinga
(MS) - Analyzing Morgan Stanley's Short Interest
Via Benzinga
Why Is Mobileye (MBLY) Stock Revving Up Today?
Shares of Mobileye are popping today, with MBLY stock surging more than 11% this afternoon on some intriguing commentary. 
Via InvestorPlace
10 Financials Stocks With Whale Alerts In Today's Session
Via Benzinga
Morgan Stanley Maintains Overweight Rating for Embraer: Here's What You Need To Know
Via Benzinga
Why Did SoundHound AI Stock Soar, Then Sink Today?
A huge gain for this up-and-coming AI stock was quickly reversed. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
The 3 Most Undervalued Dow Stocks to Buy in March 2024
Undervalued Dow Stocks are in abundance but consider these three stocks if you're seeking optimal gains in 2024 and beyond. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Investment Expert Predicts 13% Downside In S&P 500 By Year-End With 4,500 Target: 'We Don't See The Justification For Higher Multiples'
Morgan Stanley's Chief Investment Officer Mike Wilson has reiterated his bearish outlook for the stock market, citing increasing signs of speculative activity among investors. 
Via Benzinga
Topics Stocks
Exposures US Equities
EV Market Might Be Gloomy, But Morgan Stanley Says This Company Might Be a Cash Gushing Machine
Analyst initiates coverage on Phinia with Overweight rating and $50 price target. Sees potential for strong cash flows and dividends in the long-term despite current EV market challenges. 
Via Benzinga
3 Stocks to Buy as the Gig Economy Continues to Expand
The gig economy has faced a few bumps in the road, but many analysts are upbeat as the gig economy stocks look to make up for lost time. 
Via InvestorPlace
Topics Economy
Exposures Economy
Is The Tesla-Bitcoin Bromance Over? Morgan Stanley Analyst Sees Correlation Plummeting After EV Giant's Earnings Miss
Morgan Stanley analyst and Tesla (NASDAQ:TSLA) bull Adam Jonas on Monday noted that the positive correlation between 
Via Benzinga
1 Wall Street Analyst Cuts Nio's Price Target by 23%: Here's Why He's Right
This EV stock has a lot less upside thanks to declining profitability, according to a Morgan Stanley analyst. 
Via The Motley Fool
10 Financials Stocks With Whale Alerts In Today's Session
Via Benzinga
Intel-Backed Astera Labs Sets Stage for Nasdaq Debut, Aiming To Capitalize On AI Boom
Astera Labs, backed by Intel, plans to raise $534 million through IPO amid AI investment frenzy, led by Morgan Stanley and JPMorgan. 
Via Benzinga
Topics Artificial Intelligence Initial Public Offering
Exposures Artificial Intelligence Securities Market
Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know
Via Benzinga
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
Morgan Stanley initiates coverage on Arcellx. Uncover the potential of ddBCMA in blood cancer treatment, featuring a differentiated CAR-T platform. Analysts project $5 billion in peak sales. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.